<DOC>
	<DOCNO>NCT02985216</DOCNO>
	<brief_summary>A Randomized , Double-blind , Active-Controlled , Multi-center , Phase 3 Trial Compare Safety Efficacy YHD1119 Pregabalin Patients Peripheral Neuropathic Pain</brief_summary>
	<brief_title>Clinical Trial YHD1119 Patients With Peripheral Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Signed Informed Consent HbA1c â‰¤ 9.5 % diabetes mellitus patient pain 6 month Diabetic Peripheral Neuropathy postherpetic Neuralgia patient least 3 month pain diagnosis skin rash due herpes zooster Have Brittle diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>